| 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | P-value |
---|---|---|---|---|---|---|---|
Record count (% Males) | 115,382 (48%) | 134,710 (47%) | 134,832 (47%) | 143,322 (47%) | 164,734 (48%) | 182,228 (48%) | Â |
Age | 56.0 (55.9-56.1) | 55.8 (55.7-55.8) | 56.2 (56.1-56.3) | 56.5 (56.5-56.6) | 57.7 (57.6-57.7) | 58.3 (58.2-58.3) | Â |
TC dyslipidemia | |||||||
 Total | 39.0 (38.7-39.3) | 39.0 (38.7-39.3) | 38.6 (38.3-38.9) | 37.5 (37.2-37.7) | 37.0 (36.7-37.2) | 38.2 (38.0-38.4) | 0.1 |
 Female | 43.5 (43.1-43.9) | 43.2 (42.9-43.6) | 43.3 (42.9-43.6) | 42.2 (41.9-42.6) | 41.7 (41.4-42.0) | 43.6 (43.3-43.9) | 0.5 |
 Male | 34.1 (33.7-34.5) | 34.2 (33.9-34.6) | 33.4 (33.1-33.8) | 32.2 (31.9-32.6) | 31.8 (31.5-32.1) | 32.3 (32.0-32.6) | 0.02* |
HDL-C dyslipidemia | |||||||
 Total | 35.8 (35.5-36.1) | 32.6 (32.4-32.9) | 30.3 (30.0-30.6) | 32.8 (32.6-33.1) | 30.0 (29.8-30.3) | 29.0 (28.8-29.2) | 0.03* |
 Female | 37.5 (37.1-37.9) | 35.2 (3.8-35.6) | 33.7 (33.4-34.1) | 36.6 (36.2-36.9) | 34.6 (34.3-34.9) | 33.4 (33.1-33.7) | 0.2 |
 Male | 33.8 (33.3-34.2) | 29.6 (29.2-30.0) | 26.3 (26.0-26.7) | 28.5 (28.1-28.8) | 24.8 (24.5-25.1) | 24.0 (23.7-24.3) | 0.01* |
LDL-C dyslipidemia | |||||||
 Total | 35.2 (34.9-35.4) | 33.7 (33.5-34.0) | 32.5 (32.2-32.7) | 32.5 (32.3-32.8) | 31.2 (31.0-31.4) | 32.1 (31.9-32.3) | 0.02* |
 Female | 37.2 (36.8-37.6) | 35.5 (35.1-35.9) | 34.5 (34.1-34.9) | 35.1 (34.7-35.4) | 33.7 (33.4-34.0) | 35.3 (34.9-35.6) | 0.2 |
 Male | 32.9 (32.5-33.3) | 31.7 (31.3-32.1) | 30.2 (29.9-30.6) | 29.7 (29.3-30.1) | 28.5 (28.1-28.8) | 28.6 (28.3-28.9) | 0.001* |
TG dyslipidemia | |||||||
 Total | 36.4 (36.1-36.6) | 35.0 (34.8-35.3) | 36.3 (36.1-36.6) | 36.2 (35.9-36.4) | 35.6 (35.3-35.8) | 35.9 (35.6-36.1) | 0.8 |
 Female | 34.1 (33.8-34.5) | 32.9 (32.5-33.2) | 34.1 (33.8-34.5) | 34.0 (33.6-34.3) | 33.6 (33.2-33.9) | 34.1 (33.8-34.4) | 0.7 |
 Male | 38.8 (38.4-39.2) | 37.4 (37.0-37.8) | 38.8 (38.4-39.2) | 38.7 (38.3-39.1) | 37.8 (37.4-38.1) | 37.7 (37.4-38.1) | 0.5 |